These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3720768)

  • 21. [Propafenone--a new antiarrhythmic agent. Clinical experience].
    Kozák P; Stárek A; Hes I; Spacek R
    Cas Lek Cesk; 1985 Mar; 124(13):407-10. PubMed ID: 3891090
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combinations of some anti-arrhythmia drugs].
    Di Marcotullio G; Milazzotto F; Dini P; Santini M; Ceci V; Polizzi C
    G Ital Cardiol; 1984 May; 14(5):360-6. PubMed ID: 6147292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational use of antiarrhythmic drugs alone and in combination.
    Bigger JT; Giardina EG
    Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antiarrhythmic drugs.
    Troup PJ; Zipes DP
    Compr Ther; 1978 Nov; 4(11):43-8. PubMed ID: 720024
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antiarrhythmic drugs.
    Scheinman MM; Hess DS
    Am J Surg; 1983 Jun; 145(6):724-32. PubMed ID: 6407348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of angina pectoris with calcium antagonists].
    Hopf R; Becker HJ; Kober G; Dowinsky S; Kaltenbach M
    Herz; 1982 Aug; 7(4):221-34. PubMed ID: 6751971
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
    Neumann G; Grube E; Funke H
    Herz; 1983 Jun; 8(3):153-64. PubMed ID: 6873862
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic drugs: changing concepts.
    Kupersmith J
    Am J Cardiol; 1976 Jul; 38(1):119-21. PubMed ID: 937185
    [No Abstract]   [Full Text] [Related]  

  • 33. [Utilization of anti-arrhythmic drugs].
    Perrenoud JJ
    Schweiz Med Wochenschr; 1980 Jul; 110(29):1090-6. PubMed ID: 6999615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical experience with the antiarrhythmic propafenone (Rytmonorm)].
    Stejfa M; Spác J; Vítovec J; Havlát F
    Vnitr Lek; 1986 Apr; 32(4):393-7. PubMed ID: 3523975
    [No Abstract]   [Full Text] [Related]  

  • 35. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
    Pratt CM; Luck JC; Mann DE; Wyndham CR
    Cardiol Clin; 1984 Feb; 2(1):35-46. PubMed ID: 6443563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.
    Zipes DP; Troup PJ
    Am J Cardiol; 1978 May; 41(6):1005-24. PubMed ID: 352121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
    Motté G
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():7-16. PubMed ID: 6280631
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in arrhythmology].
    Furlanello F; Bettini R; Dal Forno P; Vergara G; Stefenelli C; Zuechi S; Inama G; Disertori M
    G Ital Cardiol; 1981; 11 Suppl 1():202-53. PubMed ID: 7035271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.